Cetera Investment Advisers - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 206 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cetera Investment Advisers ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$633,000
-16.7%
84,355
-0.1%
0.01%
-25.0%
Q3 2021$760,000
-24.8%
84,4000.0%0.01%
-25.0%
Q2 2021$1,010,000
-4.5%
84,4000.0%0.02%
-23.8%
Q1 2021$1,058,000
+2.7%
84,400
+27.9%
0.02%
+5.0%
Q4 2020$1,030,00066,0050.02%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders